Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe study record page no longer shows the 403 Forbidden error content, removing the previously displayed error state.SummaryDifference0.5%

- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content with an error page. This blocks access to trial details and related navigation, affecting a user’s ability to review the record.SummaryDifference18%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.6.6 appears on the page, signaling a minor update to the page metadata/content. This change does not alter the study details or results information.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small version update to the page. It does not change study content, eligibility criteria, or results; it is a background maintenance update.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, representing a minor update to the page version and accompanying content or formatting.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page's revision label was updated to v3.6.3, indicating a newer version of the page; this appears to be a minor metadata update rather than a change to study details.SummaryDifference0.1%

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.